文献速递胸部CT

中国社区低剂量CT肺癌筛查:首轮结果与荟萃分析

Community-based lung cancer screening by low-dose computed tomography in China: First round results and a meta-analysis.
PubMed 文献 · Eur J Radiol · 2021-10-01

本研究在天津开展社区低剂量CT肺癌筛查首轮,5523名参与者中肺癌检出率为0.5%,高危组1.2%、低危组0.4%,I期占70.0%。荟萃分析显示中国高危人群筛查检出率为0.6%,筛查研究中原位癌及I期比例远高于临床研究,提示筛查可能实现分期前移。

要点

  • 低剂量CT筛查肺癌检出率0.5%,高危人群1.2%,低危人群0.4%。
  • 筛查发现的肺癌中I期占70.0%,腺癌占84.4%。
  • 低危人群筛查发现的肺癌中女性占66.7%。

关键影像表现/征象

  • 筛查发现的肺癌中I期占70.0%(高危组50.0%,低危组83.3%)。
  • 筛查发现的肺癌中腺癌占84.4%(高危组61.5%,低危组100%)。
  • 低危组筛查发现的肺癌中女性占66.7%,高危组女性占8.3%。

诊断标准与关键数值

  • 社区筛查总体肺癌检出率为0.5%,高危组1.2%,低危组0.4%。
  • 中国高危人群筛查研究的汇总肺癌检出率为0.6%(95%CI:0.3%-0.9%)。
  • 筛查研究中原位癌和I期肺癌比例为76.4%(95%CI:66.3%-85.3%),临床研究为15.2%(95%CI:11.8%-18.9%)。

临床应用与阅片要点

  • 低剂量CT筛查应关注低危人群中的女性肺癌检出。
  • 筛查发现肺癌多为腺癌和早期(I期),报告时注意分期描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the efficiency of low-dose computed tomography (LDCT) screening for lung cancer in China by analyzing the baseline results of a community-based screening study accompanied with a meta-analysis.

METHODS: A first round of community-based lung cancer screening with LDCT was conducted in Tianjin, China, and a systematic literature search was performed to identify LDCT screening and registry-based clinical studies for lung cancer in China. Baseline results in the community-based screening study were described by participant risk level and the lung cancer detection rate was compared with the pooled rate among the screening studies. The percentage of patients per stage was compared between the community-based study and screening and clinical studies.

RESULTS: In the community-based study, 5523 participants (43.6% men) underwent LDCT. The lung cancer detection rate was 0.5% (high-risk, 1.2%; low-risk, 0.4%), with stage I disease present in 70.0% (high-risk, 50.0%; low-risk, 83.3%), and the adenocarcinoma present in 84.4% (high-risk, 61.5%; low-risk, 100%). Among all screen-detected lung cancer, women accounted for 8.3% and 66.7% in the high- and low-risk group, respectively. In the screening studies from mainland China, the lung cancer detection rate 0.6% (95 %CI: 0.3%-0.9%) for high-risk populations. The proportions with carcinoma in situ and stage I disease in the screening and clinical studies were 76.4% (95 %CI: 66.3%-85.3%) and 15.2% (95 %CI: 11.8%-18.9%), respectively.

CONCLUSIONS: The stage shift of lung cancer due to screening suggests a potential effectiveness of LDCT screening in China. Nearly 70% of screen-detected lung cancers in low-risk populations are identified in women.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Li Y, Du Y, Huang Y, et al. Community-based lung cancer screening by low-dose computed tomography in China: First round results and a meta-analysis. Eur J Radiol. 2021. PMID: 34695695. doi:10.1016/j.ejrad.2021.109988

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。